dr robert keller glutathione About Keller, L. Ac Videos - Robert Keller MD

One of our key strategies

For complementary metabolic pathway research through the IGF-1 receptor axis rather than beta-3 AR, IGF-1 LR3 1mg provides a mechanistically non-overlapping research tool

People using these peptides for joint injuries are in many cases operating ahead of the clinical evidence

Weeks 46 : first measurable waist or body-fat changes in responders, based on research community reports

If a provider proposes full adult dosing from day one, that is a red flag

Following a February 2026 announcement by HHS Secretary RFK Jr., the FDA removed roughly 14 of those restricted peptides from Category 2 in April 2026